S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
NASDAQ:PMVP

PMV Pharmaceuticals SEC Filings & 10K Form

$19.99
-1.76 (-8.09%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$19.95
$22.14
50-Day Range
$19.99
$30.24
52-Week Range
$19.95
$63.22
Volume
1.10 million shs
Average Volume
287,399 shs
Market Capitalization
$907.15 million
P/E Ratio
13.15
Dividend Yield
N/A
Beta
0.83

PMV Pharmaceuticals (NASDAQ:PMVP) SEC Filings

DateFilerForm TypeView
09/13/2021
7:21 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2021
3:14 PM
Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2021
3:22 PM
Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2021
7:47 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2021
6:52 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2021
7:25 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2021
4:13 PM
LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2021
4:49 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2021
3:41 PM
Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2021
4:02 PM
Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
4:53 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2021
5:06 AM
PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2021
5:03 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2021
7:34 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
5:14 PM
Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
7:17 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:56 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:39 PM
Kung Winston (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2021
6:20 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2021
5:20 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2021
4:32 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2021
7:05 PM
Desai Keval (Reporting)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
6:04 PM
Kung Winston (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
3:10 PM
Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2021
5:09 PM
Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
4:24 PM
LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
5:58 PM
Chhabra Ashvin (Reporting)
Euclidean Capital LLC (Reporting)
Greenland A LLC (Reporting)
Greenland FP LLC (Reporting)
Greenland NFP B Ltd. (Reporting)
Greenland NFP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
SIMONS JAMES H (Reporting)
Simons Marilyn (Reporting)
Symmetry Group Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
4:35 PM
Chhabra Ashvin (Reporting)
Euclidean Capital LLC (Reporting)
Greenland A LLC (Reporting)
Greenland FP LLC (Reporting)
Greenland NFP B Ltd. (Reporting)
Greenland NFP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
SIMONS JAMES H (Reporting)
Simons Marilyn (Reporting)
Symmetry Group Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
5:17 PM
Chhabra Ashvin (Reporting)
Euclidean Capital LLC (Reporting)
Greenland A LLC (Reporting)
Greenland FP LLC (Reporting)
Greenland NFP B Ltd. (Reporting)
Greenland NFP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
SIMONS JAMES H (Reporting)
Simons Marilyn (Reporting)
Symmetry Group Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
4:41 PM
PMV Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
4:39 PM
PMV Pharmaceuticals (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
4:33 PM
LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
4:30 PM
Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
4:28 PM
BAUM CHARLES M (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:24 PM
Jalota Deepika (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:22 PM
Alland Leila (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:17 PM
Kung Winston (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
6:08 PM
Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
8:36 PM
Kung Winston (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
11:04 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2021
6:13 PM
Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
5:07 PM
PMV Pharmaceuticals (Issuer)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
3:11 PM
Heyman Richard A. (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
6:41 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
6:59 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
3:52 PM
Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2021
4:38 PM
LEVINE ARNOLD J (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2021
7:01 AM
PMV Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2021
7:02 AM
PMV Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2021
7:00 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2021
6:46 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
5:10 AM
Desai Keval (Reporting)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
5:56 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2021
6:22 PM
Kung Winston (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2021
7:32 AM
PMV Pharmaceuticals (Filer)
Form DEFA14A
04/23/2021
7:30 AM
PMV Pharmaceuticals (Filer)
Form DEF 14A
04/13/2021
8:07 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2021
6:24 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2021
3:24 PM
BAUM CHARLES M (Reporting)
PMV Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/06/2021
7:50 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2021
6:04 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2021
8:25 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2021
5:20 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2021
6:34 PM
Desai Keval (Reporting)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:15 PM
PMV Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2021
3:15 PM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
3:00 PM
Nextech V Oncology S.C.S., SICAV-SIF (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G
02/12/2021
7:11 AM
Avoro Capital Advisors LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G
02/12/2021
5:07 AM
INTERWEST PARTNERS X LP (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G
12/31/2020
3:25 PM
Kung Winston (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
3:12 PM
Mack David Henry (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
7:26 AM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2020
4:23 PM
ORBIMED ADVISORS LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13D
10/05/2020
4:04 PM
PMV Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G
10/02/2020
5:42 PM
ORONSKY ARNOLD L (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4/A
10/02/2020
5:41 PM
Desai Keval (Reporting)
InterWest Management Partners X, LLC (Reporting)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4/A
09/30/2020
3:33 PM
Boxer Capital, LLC (Filed by)
PMV Pharmaceuticals (Subject)
Form SC 13G
09/29/2020
3:49 PM
Bleyer Dalia (Reporting)
Detournay Philippe (Reporting)
Lips Thomas (Reporting)
NEXTECH V GP S.A R.L. (Reporting)
Nextech V Oncology S.C.S., SICAV-SIF (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:48 PM
PMV Pharmaceuticals (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:47 PM
Chhabra Ashvin (Reporting)
Euclidean Capital LLC (Reporting)
Greenland A LLC (Reporting)
Greenland FP LLC (Reporting)
Greenland NFP B Ltd. (Reporting)
Greenland NFP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
SIMONS JAMES H (Reporting)
Simons Marilyn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:45 PM
Double Epiphany, LLC (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:44 PM
Levine Alison (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:43 PM
Dawson Samantha (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:40 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:39 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:38 PM
PMV Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:37 PM
PMV Pharmaceuticals (Issuer)
Schroeder Thilo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:35 PM
Desai Keval (Reporting)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:33 PM
ORONSKY ARNOLD L (Reporting)
PMV Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:31 PM
Bleyer Dalia (Reporting)
Detournay Philippe (Reporting)
Lips Thomas (Reporting)
NEXTECH V GP S.A R.L. (Reporting)
Nextech V Oncology S.C.S., SICAV-SIF (Reporting)
PMV Pharmaceuticals (Issuer)
Form 3/A
09/29/2020
3:30 PM
Kolchinsky Peter (Reporting)
PMV Pharmaceuticals (Issuer)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2020
3:13 PM
PMV Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
3:03 PM
PMV Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/25/2020
3:03 PM
PMV Pharmaceuticals (Filer)
Form 424B4
09/24/2020
11:15 PM
PMV Pharmaceuticals (Filer)
Form EFFECT
09/24/2020
6:36 PM
Kolchinsky Peter (Reporting)
PMV Pharmaceuticals (Issuer)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2020
6:35 PM
PMV Pharmaceuticals (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2020
6:34 PM
Nextech V Oncology S.C.S., SICAV-SIF (Reporting)
PMV Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2020
6:33 PM
Desai Keval (Reporting)
InterWest Management Partners X, LLC (Reporting)
INTERWEST PARTNERS X LP (Reporting)
Kliman Gilbert H (Reporting)
NASR KHALED (Reporting)
PMV Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2020
6:31 PM
Chhabra Ashvin (Reporting)
Euclidean Capital LLC (Reporting)
Greenland A LLC (Reporting)
Greenland FP LLC (Reporting)
Greenland NFP B Ltd. (Reporting)
Greenland NFP LLC (Reporting)
PMV Pharmaceuticals (Issuer)
SIMONS JAMES H (Reporting)
Simons Marilyn (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.